Autus Asset Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-45,659
Closed -$3.24M 161
2019
Q4
$3.24M Buy
45,659
+1,047
+2% +$76K 0.47% 64
2019
Q3
$3.34M Sell
44,612
-424
-0.9% -$35.9K 0.52% 61
2019
Q2
$3.63M Buy
45,036
+7,986
+22% +$562K 0.57% 58
2019
Q1
$2.48M Buy
37,050
+22,237
+150% +$1.68M 0.41% 68
2018
Q4
$1.1M Buy
14,813
+4,094
+38% +$338K 0.21% 78
2018
Q3
$986K Buy
+10,719
New +$1.02M 0.16% 89

Other funds holding CMD

Autus Asset Management's CMD Position: Q1 2020 in Review

Autus Asset Management sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 45,659 shares — an estimated $3.24M sold.

Autus Asset Management first reported a position in CMD in Q3 2018 and held it in 6 quarters. The position peaked at $3.63M in Q2 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Autus Asset Management reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Autus Asset Management sold 45,659 Cantel Medical Corporation shares in Q1 2020, an estimated $3.24M.
  • Autus Asset Management first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 6 quarters.
  • Autus Asset Management's Cantel Medical Corporation position peaked at $3.63M in Q2 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Autus Asset Management's 13F filing for Q1 2020, filed 16 Apr 2020.